Affiliation: University of Birmingham
- Characterisation of the endogenous human peripheral serotonin transporter SLC6A4 reveals surface expression without N-glycosylationAnita Chamba
Division of Immunity and Infection, The Medical School, University of Birmingham, Birmingham, 815 2TT, United Kingdom
J Neuroimmunol 204:75-84. 2008..Biotinylation of lymphoid cells revealed that the endogenous non-glycosylated 60 kDa but not 70 kDa protein was available at the surface to access exogenous ligands...
- The serotonin transporter (SLC6A4) is present in B-cell clones of diverse malignant origin: probing a potential anti-tumor target for psychotropicsElizabeth J Meredith
Division of Immunity and Infection, The Medical School, Birmingham, UK
FASEB J 19:1187-9. 2005....
- Enhancing the anti-lymphoma potential of 3,4-methylenedioxymethamphetamine ('ecstasy') through iterative chemical redesign: mechanisms and pathways to cell deathAgata M Wasik
School of Immunity and Infection, The Medical School, Birmingham, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK
Invest New Drugs 30:1471-83. 2012..In conclusion, MDMA analogues have been discovered with enhanced cytotoxic efficacy against lymphoma subtypes amongst which high-level Bcl-2--often a barrier to drug performance for this indication--fails to protect...
- Selective serotonin reuptake inhibitors directly signal for apoptosis in biopsy-like Burkitt lymphoma cellsAdamantios Serafeim
Medical Research Council Centre for Immune Regulation, School of Biosciences, University of Birmingham, Birmingham, United Kingdom
Blood 101:3212-9. 2003....